Sernova Corp. (TSE:SVA – Get Free Report)’s share price fell 4.5% on Friday . The stock traded as low as C$0.21 and last traded at C$0.21. 56,087 shares changed hands during trading, a decline of 64% from the average session volume of 157,444 shares. The stock had previously closed at C$0.22.
Sernova Stock Performance
The company has a debt-to-equity ratio of 16.55, a current ratio of 0.32 and a quick ratio of 18.11. The stock has a 50-day moving average price of C$0.23 and a 200-day moving average price of C$0.25. The firm has a market capitalization of C$68.32 million, a PE ratio of -1.62 and a beta of 1.35.
About Sernova
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Read More
- Five stocks we like better than Sernova
- Expert Stock Trading Psychology Tips
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Oilfield Leader SLB: An AI Name You Need to Know
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
